Community/Retail

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, discusses new trends pharmacists should know about atrial fibrillation management.

Michael Cawley, BS, PharmD, RRT, CPFT, FCCM, professor of clinical pharmacy at the University of the Sciences, demonstrates proper technique for inhaler devices.

Aralez Pharmaceuticals Inc resubmitted its new drug application to the FDA for its investigational candidate PA32540/PA8140 as secondary prevention of cardiovascular disease in patients at risk for aspirin-induced gastric ulcers.